China Resources Medical Holdings Company Limited Stock

Equities

1515

KYG2133W1087

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
4.13 HKD +3.51% Intraday chart for China Resources Medical Holdings Company Limited +11.02% -14.32%

Financials

Sales 2023 10.11B 1.39B 10.92B Sales 2024 * 10.81B 1.49B 11.67B Capitalization 4.96B 684M 5.36B
Net income 2023 258M 35.61M 279M Net income 2024 * 672M 92.74M 726M EV / Sales 2023 0.56 x
Net Debt 2023 * 633M 87.31M 683M Net cash position 2024 * 36M 4.97M 38.89M EV / Sales 2024 * 0.46 x
P/E ratio 2023
21.9 x
P/E ratio 2024 *
7.8 x
Employees 20,172
Yield 2023 *
4.83%
Yield 2024 *
3.57%
Free-Float 63.15%
More Fundamentals * Assessed data
Dynamic Chart
China Resources Medical's 2023 Profit Slides MT
China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024 CI
China Resources Medical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Resources Medical Holdings Company Limited Provides Unaudited Consolidated Earnings Guidance for the Fiscal Year Ended December 31, 2023 CI
China Resources Medical Affiliate Rents Out Hospital Buildings for Over 84 Million Yuan MT
China Resources Medical Holdings Company Limited Announces Board and Committee Changes CI
China Resources Medical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China Resources Medical Eyes 397 Million Yuan H1 Profit MT
China Resources Medical's Profit to Jump 60% in H1 MT
China Resources Medical Holdings Company Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 CI
China Resources Medical Holdings Company Limited Announces Board Changes CI
China Resources Medical Holdings Company Limited Announces Executive Changes CI
China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 19 July 2023 CI
China Resources Medical Holdings Company Limited Approves Final Dividend for the Year Ended December 31, 2022, Payable on July 19, 2023 CI
China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended December 31, 2022, Payable on 19 July 2023 CI
More news
1 day+3.51%
1 week+11.02%
Current month+5.36%
1 month+5.09%
3 months-4.18%
6 months-9.03%
Current year-14.32%
More quotes
1 week
3.76
Extreme 3.76
4.15
1 month
3.66
Extreme 3.66
4.15
Current year
3.66
Extreme 3.66
4.96
1 year
3.66
Extreme 3.66
7.63
3 years
3.50
Extreme 3.5
11.66
5 years
3.05
Extreme 3.05
11.66
10 years
3.05
Extreme 3.05
17.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 23-02-26
Director of Finance/CFO 45 23-06-12
Corporate Secretary 41 18-07-19
Members of the board TitleAgeSince
Director/Board Member 56 23-02-26
Chairman 59 18-08-06
Director/Board Member 69 18-08-06
More insiders
Date Price Change Volume
24-04-26 4.13 +3.51% 2,733,000
24-04-25 3.99 +0.76% 3,050,500
24-04-24 3.96 +2.86% 2,489,500
24-04-23 3.85 +1.05% 1,217,500
24-04-22 3.81 +2.42% 3,741,500

Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am EDT

More quotes
China Resources Medical Holdings Company Limited, formerly China Resources Phoenix Healthcare Holdings Co., Ltd, is an investment holding company mainly engaged in the group purchasing organization (GPO) business. Along with subsidiaries, the Company operates its business through four segments. The GPO Business segment is involved in the sales of pharmaceuticals, medical devices and medical consumables to Jian Gong Hospital, the Internet of things (IOT) Hospitals and external customers. The General Healthcare Services segment provides hospital services provided through Jian Gong Hospital and 999 Medical Clinic (Shenzhen) Co., Ltd. The Hospital Management and Consulting Services segment provides comprehensive management and consulting services to IOT Hospitals and sponsored hospitals and receives an annual fee. The Other Hospital-Derived Services segment provides medical consultation service to third parties.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3.823 CNY
Average target price
5.666 CNY
Spread / Average Target
+48.21%
Consensus

Annual profits - Rate of surprise